other material
confidence high
sentiment neutral
materiality 0.45
Calidi Biotherapeutics enters $5.1M ATM equity offering with Ladenburg Thalmann
Calidi Biotherapeutics, Inc.
- Company may sell up to $5.1M of common stock through ATM facility with Ladenburg Thalmann.
- Commission of 3.0% on gross proceeds; expenses up to $50k reimbursable.
- Shares sold at market prices; offering pursuant to effective S-3 registration statement.
- Company not obligated to sell any shares; can suspend at any time.